334 related articles for article (PubMed ID: 36151252)
1. A plethora of ocular surface manifestations in a multidisciplinary ocular graft-versus-host disease unit.
Trindade M; Rodrigues M; Pozzebon ME; Aranha FJP; Colella MP; Fernandes A; Fornazari DO; de Almeida Borges D; Vigorito AC; Alves M
Sci Rep; 2022 Sep; 12(1):15926. PubMed ID: 36151252
[TBL] [Abstract][Full Text] [Related]
2. Ocular surface evaluation in allogenic hematopoietic stem cell transplantation patients.
Vanathi M; Kashyap S; Khan R; Seth T; Mishra P; Mahapatra M; Tandon R
Eur J Ophthalmol; 2014; 24(5):655-66. PubMed ID: 24604604
[TBL] [Abstract][Full Text] [Related]
3. Correlation Between Tear Film Osmolarity and the Disease Score of the International Chronic Ocular Graft-Versus-Host-Disease Consensus Group in Hematopoietic Stem Cell Transplantation Patients.
Schargus M; Meyer-ter-Vehn T; Menrath J; Grigoleit GU; Geerling G
Cornea; 2015 Aug; 34(8):911-6. PubMed ID: 26075459
[TBL] [Abstract][Full Text] [Related]
4. Ocular graft versus host disease in allogenic haematopoetic stem cell transplantation in a tertiary care centre in India.
Khan R; Nair S; Seth T; Mishra P; Mahapatra M; Agarwal T; Tandon R; Vanathi M
Indian J Med Res; 2015 Nov; 142(5):543-8. PubMed ID: 26658588
[TBL] [Abstract][Full Text] [Related]
5. Dry eye disease and risk factors for corneal complications in chronic ocular graft-versus-host disease.
Kate A; Singh S; Das AV; Basu S
Indian J Ophthalmol; 2023 Apr; 71(4):1538-1544. PubMed ID: 37026297
[TBL] [Abstract][Full Text] [Related]
6. Validation of International Chronic Ocular Graft-Versus-Host Disease (GVHD) Group Diagnostic Criteria as a Chronic Ocular GVHD-Specific Metric.
Rapoport Y; Freeman T; Koyama T; Engelhardt BG; Jagasia M; Savani BN; Tran U; Kassim AA
Cornea; 2017 Feb; 36(2):258-263. PubMed ID: 28060078
[TBL] [Abstract][Full Text] [Related]
7. The Association between Meibomian Gland Atrophy and Corneal Subbasal Nerve Loss in Patients with Chronic Ocular Graft-versus-host Disease.
Dikmetas O; Kocabeyoglu S; Mocan MC
Curr Eye Res; 2021 Jun; 46(6):796-801. PubMed ID: 33427504
[No Abstract] [Full Text] [Related]
8. Ocular graft-versus-host disease (oGVHD): From A to Z.
Soleimani M; Mahdavi Sharif P; Cheraqpour K; Koganti R; Masoumi A; Baharnoori SM; Salabati M; Djalilian AR
Surv Ophthalmol; 2023; 68(4):697-712. PubMed ID: 36870423
[TBL] [Abstract][Full Text] [Related]
9. Tear Osmolarity and Ocular Surface Parameters as Diagnostic Markers of Ocular Graft-Versus-Host Disease.
Na KS; Yoo YS; Hwang KY; Mok JW; Joo CK
Am J Ophthalmol; 2015 Jul; 160(1):143-9.e1. PubMed ID: 25870935
[TBL] [Abstract][Full Text] [Related]
10. Ocular surface analysis in hematological patients before and after allogeneic hematopoietic stem cell transplantation: implication for daily clinical practice.
Giannaccare G; Bonifazi F; Sessa M; Dan E; Arpinati M; Fresina M; Bandini G; Cavo M; Versura P; Campos EC
Eye (Lond); 2017 Oct; 31(10):1417-1426. PubMed ID: 28524885
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of cataract surgery in graft-versus-host disease.
de Melo Franco R; Kron-Gray MM; De la Parra-Colin P; He Y; Musch DC; Mian SI; Niziol L; Soong HK
Cornea; 2015 May; 34(5):506-11. PubMed ID: 25826324
[TBL] [Abstract][Full Text] [Related]
12. How does ocular graft-versus-host disease fit under the dry eye umbrella? A review.
Kantor NB; Tovar A; Wang T; Galor A
Clin Exp Ophthalmol; 2024 Mar; 52(2):167-185. PubMed ID: 38204146
[TBL] [Abstract][Full Text] [Related]
13. Reduced Efficacy of Low-dose Topical Steroids in Dry Eye Disease Associated With Graft-versus-Host Disease.
Yin J; Kheirkhah A; Dohlman T; Saboo U; Dana R
Am J Ophthalmol; 2018 Jun; 190():17-23. PubMed ID: 29572107
[TBL] [Abstract][Full Text] [Related]
14. Ocular findings and ocular graft-versus-host disease after allogeneic stem cell transplantation without total body irradiation.
Pathak M; Diep PP; Lai X; Brinch L; Ruud E; Drolsum L
Bone Marrow Transplant; 2018 Jul; 53(7):863-872. PubMed ID: 29382955
[TBL] [Abstract][Full Text] [Related]
15. Comparable meibomian gland changes in patients with and without ocular graft-versus-host disease after hematopoietic stem cell transplantation.
Zhao W; Yang J; Liao Y; Lao HY; Huang Q; Jin L; Sun J; Huang F; Liang L
Ocul Surf; 2022 Jul; 25():1-7. PubMed ID: 35395386
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal analysis of meibomian gland dropout in patients with ocular graft-versus-host disease.
Hwang HS; Ha M; Kim HS; Na KS
Ocul Surf; 2019 Jul; 17(3):464-469. PubMed ID: 31015040
[TBL] [Abstract][Full Text] [Related]
17. A Review of Ocular Graft-Versus-Host Disease.
Munir SZ; Aylward J
Optom Vis Sci; 2017 May; 94(5):545-555. PubMed ID: 28422804
[TBL] [Abstract][Full Text] [Related]
18. Graft versus host disease: clinical evaluation, diagnosis and management.
Espana EM; Shah S; Santhiago MR; Singh AD
Graefes Arch Clin Exp Ophthalmol; 2013 May; 251(5):1257-66. PubMed ID: 23504086
[TBL] [Abstract][Full Text] [Related]
19. In Vivo Confocal Microscopy in Dry Eye Disease Associated With Chronic Graft-Versus-Host Disease.
Kheirkhah A; Qazi Y; Arnoldner MA; Suri K; Dana R
Invest Ophthalmol Vis Sci; 2016 Sep; 57(11):4686-91. PubMed ID: 27607414
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic serum eye drops for the treatment of dry eye patients with chronic graft-versus-host disease.
Na KS; Kim MS
J Ocul Pharmacol Ther; 2012 Oct; 28(5):479-83. PubMed ID: 22731244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
